Cancer biologists bring in the B-cell reinforcements for immunotherapy

Дата публикации: 17-09-2026 16:00:01

Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives innovations that revolutionize cancer care—innovations like immunotherapy. Immunotherapy fights cancer using the body's own immune system, often by boosting the performance of specialized adaptive immune cells called T cells.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy	0	10.91	29-09-2026
2	Metabolic activity of gut bacteria can either promote or inhibit function of CAR T cells in cancer therapy	0	6.96	28-09-2026
3	Boosted Bacille Calmette-Guérin vaccine strategy significantly reduces tuberculosis relapse, scientists find	0	9.58	17-09-2026
4	Computer-designed T-cell receptors boost attacks on cancer and viral targets in early tests	0	11.68	23-09-2026
5	'Plug-and-play' CAR T technology adapts as cancer changes	0	8.18	22-09-2026
6	Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer	0	7.48	23-09-2026
7	Immunotherapy increases risk for major cardiovascular events	0	10.61	23-09-2026
8	Making invisible cancers visible: A new route to turn 'cold' tumors 'hot'	0	7.83	17-09-2026
9	Scientists find the gene that drives T-cell exhaustion, revealing new strategy to improve immune responses	0	9.6	23-09-2026
10	Thymus health may impact mortality, cancer outcomes in adults	0	10	24-09-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.93. Источник: medicalxpress.com.